Holen Sie sich die Stockscreener-App
1.07
0.93%
-0.01
Schlusskurs vom Vortag:
$1.08
Offen:
$1.095
24-Stunden-Volumen:
8,889
Relative Volume:
0.14
Marktkapitalisierung:
$27.05M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
-0.1783
EPS:
-6
Netto-Cashflow:
$-43.02M
1W Leistung:
-4.04%
1M Leistung:
-18.32%
6M Leistung:
-6.96%
1J Leistung:
-71.08%
1-Tages-Spanne:
$1.08
$1.11
1-Wochen-Bereich:
$1.06
$1.2276
52-Wochen-Spanne:
$0.73
$3.05
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
1.08 | 27.05M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
111.01 | 196.03B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
96.55 | 140.97B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
365.14 | 138.31B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
85.02 | 109.31B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.76 | 41.90B | 6.60B | 4.16B | 490.10M | 6.93 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PR Newswire
GRIFFIN ASSET MANAGEMENT, INC. Reduces Holdings in Accelerate Di - GuruFocus.com
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2024 with Executive Guides and 5 Year Forecasts - GlobeNewswire Inc.
Accelerate Diagnostics (AXDX) – Investment Analysts’ Weekly Ratings Changes - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Antimicrobial Susceptibility Testing Market Outlook & Trends 2024: Global Forecast & Insights - WhaTech
Antimicrobial Susceptibility Testing Market Analysis - openPR
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
ACEL Stock Hits 52-Week High at $12.62 Amid Market Optimism - Investing.com UK
ACEL Stock Hits 52-Week High at $12.62 Amid Market Optimism By Investing.com - Investing.com South Africa
Accelerate Diagnostics director John Patience buys $314k in common stock - Investing.com Nigeria
Accelerate Diagnostics director Jack Schuler sells $314,000 in stock By Investing.com - Investing.com Nigeria
Accelerate Diagnostics director Jack Schuler sells $314,000 in stock - Investing.com India
Accelerate Diagnostics (NASDAQ:AXDX) Raised to “Hold” at StockNews.com - Defense World
Glox Therapeutics awarded grant to accelerate development of precision antibiotics - European Pharmaceutical Manufacturer
Microbial Identification Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031 - WhaTech
Sepsis Diagnostics Market To Grow at 8.5% By 2032Market.us Media - Market.us Media - United States Market News
Armistice Capital, LLC's Strategic Acquisition in Accelerate Dia - GuruFocus.com
William Blair Has Bearish Estimate for AXDX FY2024 Earnings - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2024 Earnings Call Transcript - Insider Monkey
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Accelerate Diagnostics: Q3 Earnings Snapshot - Houston Chronicle
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges - TipRanks
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - StockTitan
Antimicrobial Susceptibility Testing Market is Expected to Soar in the Upcoming Years - openPR
Accelerate Diagnostics (NASDAQ:AXDX) Earns Sell Rating from Analysts at StockNews.com - Defense World
BeeKeeperAI, Topcon Healthcare Collaborating on Optical Diagnostics - MPO-mag
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies - PR Newswire
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
AXDXAccelerate Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - Kilgore News Herald
Comparing Accelerate Diagnostics (NASDAQ:AXDX) & Advanced BioMedical Technologies (OTCMKTS:ABMT) - Defense World
Global study shows cefiderocol’s success in treating resistant infections - European Pharmaceutical Manufacturer
Antimicrobial Resistance Diagnostics Market to Witness an Outstanding Growth by 2032 - openPR
Antibiotic Sensitivity Testing Market Growth and Industry Overview - News in Assen
Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Defense World
Optical Imaging Market Size to Reach USD 5.61 Billion by 2033 | Straits Research - GlobeNewswire
Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution - PR Newswire
Saudi Arabia Diagnostic Imaging Market Will Accelerate Rapidly - openPR
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System - Yahoo Finance
FDA approves Accelerate Arc system to identify microbial infections - Medical Device Network
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Accelerate Diagnostics Inc-Aktie (AXDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCHULER JACK W | Director |
Dec 03 '24 |
Sale |
1.57 |
200,000 |
314,000 |
8,310,388 |
| MASSARANY HANY | Director |
Jun 28 '24 |
Option Exercise |
0.00 |
4,737 |
0 |
36,891 |
| FRANCESCONI LOUISE | Director |
Jun 28 '24 |
Option Exercise |
0.00 |
4,737 |
0 |
33,558 |
| SCHULER JACK W | Director |
Jun 28 '24 |
Option Exercise |
0.00 |
4,737 |
0 |
20,225 |
| BURRIS WAYNE | Director |
May 31 '24 |
Option Exercise |
0.00 |
839 |
0 |
1,678 |
| FRANCESCONI LOUISE | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
28,821 |
| Regan Jennifer | Director |
May 29 '24 |
Option Exercise |
0.00 |
12,631 |
0 |
12,631 |
| SCHULER JACK W | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
15,488 |
| MASSARANY HANY | Director |
May 29 '24 |
Option Exercise |
0.00 |
7,894 |
0 |
32,154 |
| Mertz Larry Michael | Chief Technology Officer |
May 20 '24 |
Option Exercise |
0.00 |
1,283 |
0 |
82,114 |
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):